Skip to main content
M

MAMOME

MaMome develops at-home fecal microbiome tests that utilize next-generation DNA sequencing and bioinformatics to detect gestational diabetes early in pregnancy. This non-invasive diagnostic tool enables timely intervention, improving health outcomes for both mothers and infants by identifying microbiome imbalances linked to pregnancy complications.

Newport Beach, United StatesFounded 20197300+ followers
Updated 4 months ago

Funding

$300K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Gestational diabetes often goes undetected until late in pregnancy, leading to potential health complications for both mother and child. Current screening methods may be invasive or inconvenient, hindering early diagnosis and timely intervention.

Solution

MaMome offers an at-home fecal microbiome test that leverages next-generation DNA sequencing and bioinformatics to enable early detection of gestational diabetes. The non-invasive test analyzes the diversity and balance of the gut microbiome, focusing on bacteria known to impact pregnancy outcomes. By identifying microbiome imbalances associated with gestational diabetes, MaMome facilitates timely intervention through nutritional education and expert consultations. The test can be administered throughout pregnancy, from the first to the third trimester (8-37 weeks of gestation), providing a convenient and accessible screening solution.

Target Audience

The primary target audience includes pregnant women seeking early and convenient screening for gestational diabetes, as well as healthcare providers looking for innovative diagnostic tools to improve maternal health outcomes.

Features

  • At-home sample collection for convenient and non-invasive testing.
  • Next-generation DNA sequencing to analyze the composition of the gut microbiome.
  • Bioinformatic analysis to identify microbiome imbalances associated with gestational diabetes.
  • Personalized reports detailing microbiome analysis results.
  • Access to nutritional education resources to promote a healthy microbiome.
  • Consultations with maternal health experts, dieticians, and microbiome specialists.
This profile is AI-generated and may contain inaccuracies.